Presentation: Strategies for Amorphous Solid Dispersion Product Development
Serán’s VP of Technology, Erica Schlesinger, PhD, presents a multifaceted approach to technology selection for enabled formulations. In this presentation, Dr. Schlesinger demonstrates how to leverage a combination of measured and calculated molecular properties, bio-performance modeling, and a strategic understanding of the product TPP to identify a technology to enable exposure and an appropriate drug product design.
KEY LEARNINGS
Strategic drug product design supports a flexible TPP that allows for development of a relevant and advanceable dosage form for FIH studies
Considering TPP/Product Design in ASD screening
Considering impact of particle properties (SDD vs HME) in product design & performance
Total Page Views: 1107
